CYP1A2 is primarily involved in caffeine metabolism, not directly in sleep regulation. It breaks down about 95% of ingested caffeine. Genetic variants (e.g., rs762551) determine whether you are a 'fast' or 'slow' caffeine metabolizer. Slow metabolizers retain caffeine longer, which can delay sleep onset and reduce sleep quality if caffeine is consumed later in the day. However, CYP1A2 itself does not cause or cure insomnia. The evidence is human-moderate: GWAS and observational studies show associations, but individual responses vary widely due to tolerance, dose, and other lifestyle factors. A DNA test alone is not a reliable predictor of sleep problems. Practical sleep hygiene—consistent bedtime, avoiding caffeine after noon—is far more impactful than knowing your CYP1A2 status.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-7865533aa358ea6757e13b2e